BCL2 and diffuse large B-cell lymphoma: Given the increasing clinical significance of BCL2 and considering therapeutic advances targeting BCL2 in hematologic malignancies, the specific definition of BCL2 positivity in DLBCL gives great promise to the study of pathophysiology of DLBCL and can be used to establish new therapeutic strategies.